Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 1/2011

01-07-2011 | Gynecologic Oncology

Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias

Authors: Faruk Abike, Ayse Basak Engin, İlkkan Dunder, Omer Lutfi Tapisiz, Canan Aslan, Lale Kutluay

Published in: Archives of Gynecology and Obstetrics | Issue 1/2011

Login to get access

Abstract

Objective

To investigate the relationship between human papilloma virus (HPV) infection persistence and serum folate, vitamin B12, homocysteine, neopterin levels in cervical dysplasia.

Study design

Through the years 2007–2008, 122 women who have admitted to Gynecology Clinic were evaluated for cervical cytology, demographical characteristics, HPV infection, serum folate, vitamin B12, homocysteine, albumin, and neopterin levels.

Results

Considering all the cases, the highest percentage of the HPV-infected patients was in high-grade squamous intraepithelial lesion (HSIL) group (83%, n = 25). The serum folate levels in all patient groups [HSIL 10.0 ± 0.4 ng/ml, low-grade squamous intraepithelial lesion (LSIL) 10.6 ± 0.5 ng/ml, atypical squamous cells-undetermined significance (ASCUS) 11.1 ± 0.8 ng/ml] were lower than control group (11.9 ± 0.5 ng/ml; p < 0.05). The vitamin B12 levels were not significantly altered in any of the patient groups. The serum homocysteine levels in all patient groups (HSIL 10.4 ± 0.5 Umol/l, LSIL 10.1 ± 0.5 Umol/l, ASCUS 10.5 ± 0.7 Umol/l) were higher than the control group (7.9 ± 0.5 Umol/l; p < 0.05). The neopterin levels of HSIL group (1.0 ± 0.2 ng/ml) were lower than the control group (1.5 ± 0.2 ng/ml; p < 0.05). The serum neopterin concentrations of HSIL with HPV group (0.6 ± 0.1 ng/ml) were significantly lower than HSIL without HPV (2.4 ± 0.9 ng/ml) and other study groups (p < 0.05). The serum homocysteine levels of HSIL HPV(+) group and LSIL HPV(+) were higher than control group (p < 0.05). The serum albumin levels of HSIL with HPV group are lower than control and other groups (p < 0.05). In all cervical dysplasia groups, folate levels in patients infected with HPV are lower than in HPV(−) patients (p < 0.05).

Conclusions

Folic acid deficiency could be caused by insufficient cellular immunity. In case of folate deficiency, the predisposition of HPV infection persistency and progression of cervical dysplasia increase. The fact that neopterin is a strong cellular immunity marker and it was detected in patients with HPV persistence and cervical dysplasia in lower levels shows that these patients may have relatively insufficient immune system. In order for dysplasia progression to be prevented, folate fortification on diets may be advised to HPV-infected women.
Literature
1.
go back to reference Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide, version 1.0. IARC Press, Lyon
2.
go back to reference Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66PubMedCrossRef Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8):S4–S66PubMedCrossRef
3.
go back to reference Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N et al (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181:1911–1919PubMedCrossRef Carter JJ, Koutsky LA, Hughes JP, Lee SK, Kuypers J, Kiviat N et al (2000) Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis 181:1911–1919PubMedCrossRef
4.
go back to reference Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef Bosch FX, Lorincz A, Munoz N et al (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef
5.
go back to reference Chew GK, Cruickshank ME, Rooney PH, Miller ID, Parkin DE, Murray GI (2005) Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 93:1301–1304PubMedCrossRef Chew GK, Cruickshank ME, Rooney PH, Miller ID, Parkin DE, Murray GI (2005) Human papillomavirus 16 infection in adenocarcinoma of the cervix. Br J Cancer 93:1301–1304PubMedCrossRef
6.
go back to reference (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papilloma viruses. International Agency for Research on Cancer, Lyon (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papilloma viruses. International Agency for Research on Cancer, Lyon
7.
go back to reference Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127(8):930–934PubMed Schiffman M, Castle PE (2003) Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 127(8):930–934PubMed
8.
go back to reference ASCUS-LSIL Traige Study (ALTS) Group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188(6):1393–1400 ASCUS-LSIL Traige Study (ALTS) Group (2003) A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 188(6):1393–1400
9.
go back to reference Whitehead N, Reyner F, Lindenbaum J (1973) Megaloblastic changes in the cervical epithelium. J Am Med Assoc 226:1421–1424CrossRef Whitehead N, Reyner F, Lindenbaum J (1973) Megaloblastic changes in the cervical epithelium. J Am Med Assoc 226:1421–1424CrossRef
10.
11.
go back to reference Mason JB, Levesque T (1996) Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Basel) 10:1727–1742 Mason JB, Levesque T (1996) Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Basel) 10:1727–1742
12.
go back to reference Weir DG, Scott JM (1999) Cobalamins: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 394–401 Weir DG, Scott JM (1999) Cobalamins: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 394–401
13.
go back to reference McPartlin J, Weir DG, Scott JM (1999) Folic acid: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 803–811 McPartlin J, Weir DG, Scott JM (1999) Folic acid: physiology, dietary sources and requirements. In: Sadler MJ, Strain JJ, Caballero B (eds) Encyclopedia of human nutrition. Academic Press, London, pp 803–811
14.
go back to reference Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis and the homocysteine–folate–cobalamin triad: do we need standardized analyses? J Am Coll Nutr 16:258–267PubMed Flynn MA, Herbert V, Nolph GB, Krause G (1997) Atherogenesis and the homocysteine–folate–cobalamin triad: do we need standardized analyses? J Am Coll Nutr 16:258–267PubMed
15.
go back to reference Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid, total homocysteine determinations for diagnosing cobalamin, folate deficiencies. Am J Med 96(3):239–246PubMedCrossRef Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994) Sensitivity of serum methylmalonic acid, total homocysteine determinations for diagnosing cobalamin, folate deficiencies. Am J Med 96(3):239–246PubMedCrossRef
16.
go back to reference Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD (2001) Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12(4):317–324PubMedCrossRef Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, Hamman RF, Levine RS, Mallin K, Stolley PD (2001) Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer Causes Control 12(4):317–324PubMedCrossRef
17.
go back to reference Kwaśniewska A, Tukendorf A, Goździcka-Józefiak A, Semczuk-Sikora A, Korobowicz E (2002) Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 23(4):311–316PubMed Kwaśniewska A, Tukendorf A, Goździcka-Józefiak A, Semczuk-Sikora A, Korobowicz E (2002) Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. Eur J Gynaecol Oncol 23(4):311–316PubMed
18.
go back to reference Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss C, Werner R, Werner-Febmayer C (1992) Neopterin: biochemistry, methods, clinical applications. Walter de Gruyter, New YorkCrossRef Wachter H, Fuchs D, Hausen A, Reibnegger G, Weiss C, Werner R, Werner-Febmayer C (1992) Neopterin: biochemistry, methods, clinical applications. Walter de Gruyter, New YorkCrossRef
19.
go back to reference Reibnegger CJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzeb HM, Lutz H, Werner ER, Wachter H (1986) Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 46:950–955PubMed Reibnegger CJ, Bichler AH, Dapunt O, Fuchs DN, Fuith LC, Hausen A, Hetzeb HM, Lutz H, Werner ER, Wachter H (1986) Neopterin as a prognostic indicator in patients with carcinoma of the uterine cervix. Cancer Res 46:950–955PubMed
20.
go back to reference Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3–4):307–341PubMedCrossRef Fuchs D, Weiss G, Reibnegger G, Wachter H (1992) The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases. Crit Rev Clin Lab Sci 29(3–4):307–341PubMedCrossRef
21.
go back to reference Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA (2007) C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107(1):114–117PubMedCrossRef Polterauer S, Grimm C, Tempfer C, Sliutz G, Speiser P, Reinthaller A, Hefler LA (2007) C-reactive protein is a prognostic parameter in patients with cervical cancer. Gynecol Oncol 107(1):114–117PubMedCrossRef
22.
go back to reference Yamada N, Nakayama A, Kubota K, Kawakami A, Suzuki E (2008) Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 56(5):409–415PubMed Yamada N, Nakayama A, Kubota K, Kawakami A, Suzuki E (2008) Structure and function changes of oxidized human serum albumin: physiological significance of the biomarker and importance of sampling conditions for accurate measurement. Rinsho Byori 56(5):409–415PubMed
23.
go back to reference Chandra S, Chandra RK (1986) Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1–65PubMed Chandra S, Chandra RK (1986) Nutrition, immune response, and outcome. Prog Food Nutr Sci 10:1–65PubMed
24.
go back to reference Dhur A, Galan P, Hercberg S (1991) Folate status and the immune system. Prog Food Nutr Sci 15:43–60PubMed Dhur A, Galan P, Hercberg S (1991) Folate status and the immune system. Prog Food Nutr Sci 15:43–60PubMed
25.
go back to reference Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195PubMedCrossRef Wilke CM, Hall BK, Hoge A, Paradee W, Smith DI, Glover TW (1996) FRA3B extends over a broad region and contains a spontaneous HPV 16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5:187–195PubMedCrossRef
26.
go back to reference Popescu NC, DiPaolo JA, Amsbaugh SC (1987) Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44:58–62PubMedCrossRef Popescu NC, DiPaolo JA, Amsbaugh SC (1987) Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44:58–62PubMedCrossRef
27.
go back to reference Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D (2003) Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 17:A373 Piyathilake CJ, Henao OL, Meleth S, Partridge E, Heimburger D (2003) Folate is associated with the acquisition, persistence and clearance of high-risk (HR) human papillomavirus (HPV). FASEB J 17:A373
28.
go back to reference Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC et al (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788–8793PubMedCrossRef Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC et al (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64:8788–8793PubMedCrossRef
29.
go back to reference Piyathilake CJ, Macaluso M, Brill I, Heimburger DC, Partridge EE (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23(3):203–210PubMedCrossRef Piyathilake CJ, Macaluso M, Brill I, Heimburger DC, Partridge EE (2007) Lower red blood cell folate enhances the HPV-16-associated risk of cervical intraepithelial neoplasia. Nutrition 23(3):203–210PubMedCrossRef
30.
go back to reference Kwaśniewska A, Tukendorf A, Semczuk M (1997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18(6):526–530PubMed Kwaśniewska A, Tukendorf A, Semczuk M (1997) Folate deficiency and cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 18(6):526–530PubMed
31.
go back to reference Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64(23):8788–8793PubMedCrossRef Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE (2004) Folate is associated with the natural history of high-risk human papillomaviruses. Cancer Res 64(23):8788–8793PubMedCrossRef
32.
go back to reference Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45(1):47–53PubMedCrossRef Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45(1):47–53PubMedCrossRef
33.
go back to reference Oner N, Vatansever U, Karasalihoğlu S, Ekuklu G, Celtik C, Biner B (2006) The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc Health 38(5):599–606PubMedCrossRef Oner N, Vatansever U, Karasalihoğlu S, Ekuklu G, Celtik C, Biner B (2006) The prevalence of folic acid deficiency among adolescent girls living in Edirne, Turkey. J Adolesc Health 38(5):599–606PubMedCrossRef
Metadata
Title
Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias
Authors
Faruk Abike
Ayse Basak Engin
İlkkan Dunder
Omer Lutfi Tapisiz
Canan Aslan
Lale Kutluay
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 1/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1650-7

Other articles of this Issue 1/2011

Archives of Gynecology and Obstetrics 1/2011 Go to the issue

Materno-Fetal Medicine

The history of vaginal birth